These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-000121-30 An Open Label Pilot study with oral fludarabine, oral cyclophosphamide and CAMPATH 1H (FCC) for patients with refractory or Relapsed B cells Chronic Lynphocytic Leukaemia 2013-08-02 due-trials
Completed, but no date 2007-004358-10 EVALUATION OF THE TOLERABILITY AND EFFICACY OF ERYTHROPOIETIN (EPO) TREATMENT IN SPINAL SHOCK: COMPARATIVE STUDY VS METHYLPREDNISOLONE (MP) bad-data
Completed, but no date 2007-004370-55 Effects of tetrahydrobiopterin (6R-BH4) on flow-mediated dilation in CADASIL patients: a randomised controlled trial bad-data
Completed, but no date 2007-004512-32 SYNTHESIS: A RANDOMIZED CONTROLLED TRIAL ON INTRA-ARTERIAL VERSUS INTRAVENOUS THROMBOLYSIS IN ACUTE ISCHEMIC STROKE bad-data
Ongoing 2007-005831-27 Use of rHuEpo before autologous hematopoietic stem cell transplantation in patients affected by multiple myeloma, non Hodgkin disease and breast cancer to reduce transfusional requirement after myeloa... not-yet-due
Completed, but no date 2007-007007-32 Efficacy of IVIG in the treatment of treatment-resistent painful neuropathy bad-data
Reported results 2008-000561-28 Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of bridging antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. 2009-10-15 due-trials
Completed, but no date Terminated 2008-003666-26 A double-blind, randomized trial of ARNICA comp.-Heel treatment in patients undergoing hemorrhoidectomy in day surgery: evaluation of postoperative pain bad-data
Not reported Terminated 2009-014769-16 REWORD-HF REverse WOrsening Renal function in Decompensated Heart Failure Impact of different therapeutic approaches in patients with cardiorenal syndrome in the setting of acute decompensated cong... 2013-06-20 due-trials
Not reported Terminated 2009-016958-41 Early LEvosimendan Vs usual care in Advanced chronic hearT failurE 2014-05-31 due-trials
Ongoing 2010-018353-36 BeTACTIC Study. Best Therapy After Cardiac Transplantation, the Italian Challenge. A multicenter, prospective, randomized, open-label study to compare the efficacy and safety of Everolimus and Mycoph... not-yet-due
Reported results 2010-022332-37 A SINGLE-ARM MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA 2015-11-18 due-trials
Completed, but no date Terminated 2010-023883-42 Randomized, double-blind, placebo controlled trial to evaluate the efficacy of high dose intravenous immunoglobulins in diabetic painful polyneuropaty (DPNP)resistant to conventional therapies Stud... bad-data
Completed, but no date, and reported results 2011-002080-21 Open-label phase 2 study of dacarbazine in patients with metastatic colorectal carcinoma based on expression of O6-methylguanine-DNA-methyltransferase (MGMT) Studio aperto di fase II sull'attivita... bad-data
Completed, but no date 2012-003338-17 Phase II study of temozolomide in metastatic colorectal cancer patients resistant to standard therapies and with O6-methylguanine-DNA methyltransferase (MGMT) promoter hypermethylation Studio di... bad-data
Ongoing 2012-004118-33 High-dose cyclophosphamide role in the prophylaxis of GVHD in elderly patients (66-70 years) with acute leukemia or myelodysplasia high-risk, submitted to allogenic transplant of peripheral hematopoie... not-yet-due
Ongoing 2012-005062-34 An open label, single arm, phase II study of nilotinib 300 mg BID in newly diagnosed CP-CML patients, in order to verify disappearance of CD34+/lin-Ph+ cells from bone marrow during treatment. Stud... not-yet-due
Ongoing 2014-002672-86 PHASE II CLINICAL TRIAL FOR A STEPWISE PROGRESSION IN THE TREATMENT OF CARDIOGENIC SHOCK STUDIO DI FASE II PER LA VALUTAZIONE DI UN APPROCCIO TERAPEUTICO MULTISTEP IN PAZIENTI CON SHOCK CARDIOGENO ... not-yet-due
Ongoing 2017-002094-18 Prospective evaluation of a continuation therapy with Midostaurin in adult patients with core-binding factor leukemia and integrated genetic analysis: a multi-center phase II study Valutazione pros... not-yet-due
Ongoing 2017-003671-60 TOTAL NEOADJUVANT TREATMENT WITHOUT SURGERY FOR LOCALLY ADVANCED RECTAL CANCER: PROSPECTIVE CLINICAL TRIAL TO ASSESS TUMOR COMPLETE RESPONSE, CIRCULATING TUMOR GENETIC AND EPIGENETIC BIOMARKERS, AND S... not-yet-due
Ongoing 2018-005028-40 A Multi-Center, Open Label, Uncontrolled, Phase II Clinical Trial Evaluating the Safety and Efficacy of Venetoclax in Combination with Atezolizumab and Obinutuzumab in Richter Transformation of CLL ... not-yet-due
Completed, but no date Terminated 2020-001708-41 Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: comparison of 40 mg o.d. versus 40 mg b.i.d. A randomized Clinical Trial Enoxaparina per la tromboprofilassi di pazienti ospedal... bad-data
Ongoing 2021-000938-34 Single blind randomized controlled trial to assess the safety and efficacy of high dose pulse intravenous corticosteroid therapy to treat patients with complicated/fulminant acute myocarditis not-yet-due
Ongoing 2022-003912-99 Single-blinded randomized investigator-driven controlled trial to assess the efficacy of colchicine to treat patients with cardiomyopathy with myocarditis (chronic inflammatory cardiomyopathy) CMP-MY... not-yet-due